Accessibility Menu
Moolec Science logo

Moolec Science(NASDAQ) MLEC

Market Cap$5.18MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)-94%
5 Year-100%
1 Year-60%
1 Month-1%
$7.15
+4.99%
+0.34Today
Pre market$7.56+$0.41 (+5.73%)
Moolec Science last closing stock price
MetricPriceDate
Last closeUSD 7.142026-09-03
Moolec Science stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+4.84%USD 6.812026-08-27
1 month-0.88%USD 7.202026-08-04
3 month-4.42%USD 7.472026-06-05
Year to date+86.96%USD 3.822025-12-31
1 year-60.33%USD 18.002025-09-03
3 year-98.54%USD 490.502023-09-01
5 year-99.51%USD 1,470.002021-09-02
Since inception-93.94%USD 117.902025-06-18

Moolec Science Financials at a Glance

Market Cap

$5.18MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$7.83M

Net Income (TTM)

-$8.28M

EPS (TTM)

$0.00

P/E Ratio

-0.22

Dividend

$0.00

Beta (Volatility)

0.15 (Low)

Price

$7.15

Volume

401

Open

$6.80

Previous Close

$7.14

Daily Range

$6.78 - $7.20

52-Week Range

$3.08 - $23.22

Estimated Earnings Date

May 14, 2026

MLEC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Moolec Science

Moolec Science S.A. is a biotechnology company focused on developing innovative ingredients for food, pet food, animal feed, and dietary supplements. Utilizing molecular farming technology and precision fermentation, the company aims to revolutionize the food industry with sustainable and nutritious alternatives.

Products and Services
  • Development of nutritional supplements and food ingredients
  • Production of meat replacements and by-products
  • Utilization of diverse raw materials like safflowers and chickpeas
Growth Outlook
  • Projected increase in demand for plant-based ingredients globally
  • Expansion into new markets with innovative product offerings
  • Strategic partnerships to enhance research and development capabilities
Financial Highlights
  • Recent quarterly revenue of $2.64 million, showing growth potential
  • Trailing twelve months (TTM) revenue of $10.5 million, indicating market traction
  • Operating expenses reflect ongoing investment in R&D and marketing
Moolec Science S.A. operates in a rapidly evolving sector, where the demand for sustainable food solutions is increasing. The company's focus on molecular farming technology positions it well to capitalize on this trend. Recent financial data indicates a growing revenue stream, with a notable quarterly revenue of $2.64 million, suggesting a positive trajectory. The TTM revenue of $10.5 million further underscores the company's potential for growth in the competitive biotechnology landscape. Investors may find Moolec Science S.A. an intriguing opportunity, given its innovative approach and commitment to sustainability in food production. The ongoing investments in research and development, alongside strategic partnerships, are expected to drive future growth and enhance market presence.
AI Generated • Aug 22, 2026

Industry

Food Products

Employees

103

CEO

Gastón Paladini, MBA

Headquarters

Grand Cayman, GT KY1-9009, KY

MLEC Financials

Key Financial Metrics (TTM)

Gross Margin

34.17%

Operating Margin

-3.14%

Net Income Margin

-33.41%

Return on Equity

376.84%

Return on Capital

-5.79%

Return on Assets

-54.45%

Earnings Yield

-4.55%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.18MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

726.10K

Volume

401

Avg. Volume

14.28K

Financials (TTM)

Gross Profit

-$639.50K

Operating Income

-$9.14M

EBITDA

-$5.21M

Operating Cash Flow

-$5.70M

Capital Expenditure

-$419.96K

Free Cash Flow

-$6.12M

Cash & ST Invst.

$1.08M

Total Debt

$66.48M

Moolec Science Performance Analysis

Moolec Science annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 0N/A
20232023-06-30USD 905,049N/A
20242024-06-30USD 466,376,33051430.5%
20252025-06-30USD 333,611,248-28.5%
Moolec Science sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-27.8%
Q12024-09-302.2%
Q22024-12-3169.7%
Q22025-12-31N/A
Moolec Science annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.81N/A
20232023-06-30USD -225.3927725.9%
20242024-06-30USD -842.19273.7%
20252025-06-30USD -258.69-69.3%
Moolec Science sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-75.0%
Q12024-09-3028.6%
Q22024-12-31-20.0%
Q22025-12-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

$2.64M

+948.3%

Gross Profit

-$674.37K

-7285.5%

Gross Margin

-25.52%

N/A

Market Cap

$5.18MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$50.33K

N/A

Employees

103

N/A

Net Income

-$2.43M

-36.1%

EBITDA

-$1.15M

+33.5%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Total Cash

$1.08M

-74.7%

Total Debt

$66.48M

+378.6%

Accounts Receivable

$3.97M

+128.2%

Inventory

$3.99M

+930.1%

Long Term Debt

$12.03M

+10.3%

Short Term Debt

$54.45M

+1723.2%

Return on Assets

-54.45%

N/A

Return on Invested Capital

33.43%

N/A

Free Cash Flow

-$1.19M

+70.6%

Operating Cash Flow

-$890.48K

+78.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GLMDGalmed Pharmaceuticals Ltd.
$3.92-4.83%
GTBPGT Biopharma, Inc.
$0.25-10.81%
ELABPMGC Holdings Inc.
$5.23+2.75%
NCELNewcelX Ltd.
$3.35+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$10.38+0.11%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$106.74+0.00%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$51.60-0.00%
IBITiShares Bitcoin Trust
$46.35+0.06%

Questions About MLEC

What is the current price of Moolec Science?

Moolec Science is trading at $7.14 per share.

What is the 52-week range for Moolec Science?

Over the past 52 weeks, Moolec Science has traded between $3.08 and $23.22.

How much debt does Moolec Science have?

As of the most recent reporting period, Moolec Science reported total debt of $22.09M.

How much cash does Moolec Science have on hand?

Moolec Science reported $1.93M in cash and cash equivalents in its most recent financial results.

What is Moolec Science’s dividend yield?

Moolec Science does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.